Search

Your search keyword '"Casale T."' showing total 816 results

Search Constraints

Start Over You searched for: Author "Casale T." Remove constraint Author: "Casale T."
816 results on '"Casale T."'

Search Results

1. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

9. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

10. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

11. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

12. The ARIA-MeDALL hypothesis

20. Relation between reduction in fractional exhaled nitric oxide and efficacy in asthma patients treated with dupilumab

27. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products

28. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

29. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

30. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

32. Development and validation of combined symptom-medication scores for allergic rhinitis*

33. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model

34. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data

35. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

36. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

38. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

41. EAACI Biologicals Guidelines—Recommendations for severe asthma

42. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

43. Management of anaphylaxis due to COVID-19 vaccines in the elderly

44. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

47. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

49. Efficacy and safety of treatment with dupilumab for severe asthma : A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma

50. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

Catalog

Books, media, physical & digital resources